Hans Ausloos, Oud maar niet verouderd: een inleiding tot de studie van het Oude Testament by S. D. Snyman

“…Die boek is die neerslag van lesings wat aangebied is as deel van ’n kursus in “Inleiding tot de studie van het Oude Testament-Religie” aan beginnerstudente. …”
Get full text

Hans Ausloos en Benedicte Lemmelijn, De Bijbel: een (g)oude(n) gids: Bijbelse antwoorden op menslijke vragen by S. D. Snyman

Get full text

Contemporary Trends of the Epidemiology, Clinical Characteristics, and Resource Utilization of Necrotizing Fasciitis in Texas: A Population-Based Cohort Study by Lavi Oud, Phillip Watkins

Get full text

Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study by Jaimie P. Meyer, Stacey Brunson, Carolina R. Price, Morgan Mulrain, Julie Nguyen, Frederick L. Altice, Tassos C. Kyriakides, Karen Cropsey, Ellen Eaton

Subjects: Get full text

Fabrication and Dissolution of Americium Plutonium Oxide Fuels by de Visser – Týnová Eva, Bruin Jessica, Oud Frank

Get full text

Estimating the Prevalence of Opioid use Disorder in the Cincinnati Region using Probabilistic Multiplier Methods and Model Averaging by Peter J. Mallow, Nila Sathe, Michael Topmiller, Jennifer Chubinski, Dillon Carr, Roni Christopher

“…**Background:** Opioid use disorder (OUD) and its consequences have strained the resources of health, social, and criminal justice services in the Cincinnati region. …”
Get full text

Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study by Nahiyan Bin Noor, George Pro, Mahip Acharya, Hari Eswaran, Corey J. Hayes

“…Objective: This study assessed the impact of different modalities of delivery of opioid use disorder (OUD)-related care on several patient outcomes. Methods: This study was conducted among patients newly diagnosed with OUD and receiving OUD-related care between March 2020 and March 2022, using data from Epic Cosmos. …”
Get full text

Serotonin circuits act cooperatively with pathophysiology of opioid use disorder by Arakawa Hiroyuki, Ozawa Akihiko

“…It has been imperative to establish modulatory mechanisms and alternative treatments to mitigate OUD. This review deals with central serotonin (5-HT) system as a cooperative mediator with OUD-related neural processing. …”
Get full text

The Impact of Preoperative Opioid Use Disorder on Complications and Costs following Primary Total Hip and Knee Arthroplasty by Jacob M. Wilson, Kevin X. Farley, Matthew Aizpuru, Eric R. Wagner, Thomas L. Bradbury, George N. Guild

“…Coarsened exact matching was used to statistically match the OUD and non-OUD cohorts. Further analysis was then conducted on matched cohorts with multivariate analysis. …”
Get full text

Cognitive Impairment in Opium Use Disorder by Hossein Sanjari Moghaddam, Behrang Shadloo, Helen Shahkhah, Abbas Tafakhori, Maryam Haghshomar, Shakila Meshkat, Vajiheh Aghamollaii

“…This cross-sectional study is aimed at assessing the effects of opium use disorder (OUD) on attention, working memory, and information-processing speed. …”
Get full text

A deep learning analysis for dual healthcare system users and risk of opioid use disorder by Ying Yin, Elizabeth Workman, Phillip Ma, Yan Cheng, Yijun Shao, Joseph L. Goulet, Friedhelm Sandbrink, Cynthia Brandt, Christopher Spevak, Jacob T. Kean, William Becker, Alexander Libin, Nawar Shara, Helen M. Sheriff, Jorie Butler, Rajeev M. Agrawal, Joel Kupersmith, Qing Zeng-Trietler

“…Interestingly, a history of other drug use interacted negatively with dual-system use regarding OUD risk. In contrast, older age was associated with a lower risk of OUD but interacted positively with dual-system use. …”
Get full text

Perioperative Management of a Patient Taking Suboxone® at the Time of Ambulatory Surgery by Shawn H. Malan, Christopher H. Bailey, Narjeet Khurmi

“…These properties make it an effective tool in treating OUD and abuse. However, despite its advantages in treating OUD and abuse, buprenorphine can make it difficult to control acute perioperative pain. …”
Get full text

Subcutaneous Extended-Release Buprenorphine Use in Pregnancy by Craig V. Towers, Heather Deisher

“…Background. Opioid use disorder (OUD) in pregnancy is managed by medication-assisted treatment. …”
Get full text

Disparities in Opioid Use Disorder Treatment Admissions in the United States by Peter J. Mallow, Michael Mercado, Michael Topmiller

“…Within Cincinnati, there does not appear to be a racial disparity in treatment type or length of time to receive treatment for OUD.…”
Get full text

Patients' perspectives on buprenorphine subcutaneous implant: a case series by Claudio Pierlorenzi, Marco Nunzi, Sabino Cirulli, Giovanni Francesco Maria Direnzo, Lucia Curatella, Sandra Liberatori, Annalisa Pascucci, Edoardo Petrone, Generoso Ventre, Concettina Varango, Maria Luisa Pulito, Antonella Varango, Cosimo Dandolo, Brunella Occupati, Roberta Marenzi, Claudio Leonardi

“…Thus, the purpose of the study is to evaluate how the introduction of a novel OAT approach influences these key factors in the management of OUD. Case presentation This article marks the pioneering use of OAT through buprenorphine implant in Europe and delves into the experience of six patients diagnosed with OUD at a relatively young age. …”
Get full text

Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment by Annabelle M Belcher, Thomas O Cole, Aaron D Greenblatt, Stephen W Hoag, David H Epstein, Michael Wagner, Amy S Billing, Ebonie Massey, Kristen R Hamilton, Zofia K Kozak, Christopher J Welsh, Eric Weintraub, Emerson M Wickwire, Eric D Wish, Ted J Kaptchuk, Luana Colloca

“…Introduction More than 2 million individuals in the USA have an opioid use disorder (OUD). Methadone maintenance treatment is the gold standard of medication-based treatment for OUD, but high-dose methadone is associated with cardiotoxicity and respiratory complications, among other side effects. …”
Get full text

Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care. by Tea Rosic, Glenda Babe, Myanca Rodrigues, Brittany B Dennis, Richard Perez, Claire de Oliveira, Andrew Worster, Lehana Thabane, Zainab Samaan

“…<h4>Background</h4>Individuals with opioid use disorder (OUD) have a high prevalence of co-occurring mental health disorders; however, there exists little information on mental health service use for this population. …”
Get full text

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review by Brian Hutton, Beverley Shea, Kimberly Corace, David Moher, Danielle B Rice, Becky Skidmore, Kednapa Thavorn, Sheena Taha, Dianna Wolfe, Fatemeh Yazdi, Beth A Sproule, Melanie Willows, Patricia Poulin, Gary Garber, Amy Porath, Leila Esmaeilisaraji

“…If sufficient data and adequate homogeneity exists, network meta-analyses (NMA) will be performed.Ethics and dissemination This will be the first systematic review to incorporate NMA to compare psychosocial treatments used as an adjunct to opioid agonist therapy for OUD. Results of this review will inform clinical management of persons with OUD.Trial registration number CRD42018090761.…”
Get full text

“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits by Mariya Masyukova, Benjamin T. Hayes, Teresa López-Castro, Aaron D. Fox

“…Participants were persons with opioid use disorder (OUD) who had previously received BUP treatment. …”
Get full text

Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder by Nicholas C. Cardamone, Rebecca E. Stewart, Kyle M. Kampman, Steven C. Marcus

“…Yet, use of MOUD among people with opioid use disorder (OUD) remains low. Interventions to increase MOUD access in the United States have largely focused on improving organizational capacity and addressing funding barriers, yet stigma toward MOUD may inhibit uptake even where MOUD is readily available. …”
Get full text